Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: A retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 12, 1996, Pages 1179-1183

  Moody, G A ^a   Jayanthi, V ^a   Probert, C S J ^a   Mac Kay, H ^a   Mayberry, J F ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Colectomy; Colorectal cancer; Sulphasalazine; Ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID DERIVATIVE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CLINICAL ARTICLE; COHORT ANALYSIS; COLON RESECTION; COLORECTAL CANCER; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; ULCERATIVE COLITIS; UNITED KINGDOM;

EID: 0029803955     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199612000-00009     Document Type: Article

References (26)

1. Eckbom A, Helmick C, Zack M, Adami HO: Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990, 323:1228-1233.
2. Gyde S: Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut 1990, 31:1089-1092.
3. Collins RH, Feldman M, Fordtran JS: Colon cancer, dysplasia and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 1987, 316(26):1654-1658.
4. Bostrum O, Lotberg R, Ost A, Reichard H: Cancer surveillance of patients with long standing ulcerative colitis: a clinical, endoscopical and histological study. Gut 1986, 27:1408-1413.
5. Lennard-Jones JE, Ritchie JK, Morson BC, Williams CB: Cancer surveillance in ulcerative colitis. Lancet 1983, 149-152.
6. Rosenstock E, Farmer RG, Petras R, Sivack MV Jr, Rankin GB, Sullivan BH: Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985, 89:1342-1346.
7. Prior P, Gyde SN, McCartney JC, Thompson H, Waterhouse JAH, Allan RN: Cancer morbidity in ulcerative colitis. Gut 1982, 23:490-497.
8. Nugent FW, Haggitt RC, Gilpin PA: Cancer surveillance in ulcerative colitis. Gastroenterology 1991, 100:1241-1248.
9. MacDougal IPM, Lond MD: The cancer risk in ulcerative colitis. Lancet 1964, 655-658.
10. Jayanthi V, Probert CSJ, Pinder D, Wicks ACB, Mayberry JF: The epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicester. QJM 1992, 82:125-138.
11. Probert CSJ, Jayanthi V, Pinder D, Wicks ACB, Mayberry JF: The epidemiology of ulcerative colitis in Indian migrants and the indigenous population in Leicester. Gut 1992, 33:113-125.
12. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO: Risk factors for colorectal cancer in patients with ulcerative colitis: a case control study. Gastroenterology 1994, 107:117-120.
13. Levin B, Lennard-Jones L, Riddell RH, Sachar D, Winawer SJ, WHO Collaborating Centre for the Prevention of Colorectal Cancer: Surveillance of patients with chronic ulcerative colitis. Bull World Health Organ 1991, 69:121-126.
14. Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, et al.: Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988, 29:206-217.
15. Katzka I, Broom R, Morris E, Icatz S: Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from private practice. Gastroenterology 1983, 85:22-29.
16. Bostrom O, Llofbery R, Nordenvall B, Ost A, Kellers C: The risk of colorectal cancer in ulcerative colitis: an epidemiologic study. Scand J Gastroenterol 1987, 221:1193-1199.
17. Gilal T, Fireman A, Grossman A, Malcomen D: Colorectal cancer in patients with ulcerative colitis: a population study in central Israel. Gastroenterology 1988, 94:870-877.
18. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO: Risk factors for colorectal cancer in patients with ulcerative colitis: a case control study. Gastroenterology 1994, 107:117-120.
19. Langholz E, Munkholm P, Davidsen M, Binder V: Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastreonterology 1992, 103:1444-1451.
20. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S: A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst 1991, 83:355-358.
21. Jaffe BM: Prostaglandins and cancer. An update. Prostaglandins 1974, 6:453-461.
22. Lupulescu A: Enhancement of carcinogenesis by prostaglandins Nature 1978, 272:634-636.
23. Lynch NR, Castes M, Astoin M: Mechanism of inhibition of tumour growth by aspirin and indomethacin. Br J Caner 1978, 38:503-512.
24. Logan RF, Little J, Houghton PG, Hardcastle JD: Effect of aspirin and NSAIDs on colorectal adenomas. Case control study of patients participating in the Nottingham FOB screening programme. BMJ 1993, 303:285-289.
25. Davis AE, Patterson F, Crouch R: The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model. Br J Cancer 1992, 66:777-780.
26. Waddell WR, Loughry RW: Suldinac for polyposis of the colon. J Surg Oncol 1983, 24:83-87.